366 related articles for article (PubMed ID: 11289737)
1. Papillary and follicular thyroid carcinoma.
Schlumberger MJ; Torlantano M
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status.
Schlumberger MJ
J Endocrinol Invest; 1999; 22(11 Suppl):3-7. PubMed ID: 10726999
[TBL] [Abstract][Full Text] [Related]
3. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
[TBL] [Abstract][Full Text] [Related]
4. Treatment of locally aggressive well-differentiated thyroid cancer.
Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
[TBL] [Abstract][Full Text] [Related]
5. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of thyroid cancer patients with favorable prognostic indicators.
Leboulleux S; Baudin E; Schlumberger M
Ann Endocrinol (Paris); 2003 Feb; 64(1):64-7. PubMed ID: 12707639
[No Abstract] [Full Text] [Related]
8. [Current state of the treatment of thyroid cancer].
Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
11. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of papillary carcinoma of the thyroid gland.
Rosenbaum MA; McHenry CR
Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
[TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
16. Controversies in the surgical management of differentiated thyroid carcinoma.
Noguchi M; Katev N; Miyazaki I
Int Surg; 1996; 81(2):163-7. PubMed ID: 8912084
[TBL] [Abstract][Full Text] [Related]
17. Postsurgical management of differentiated thyroid carcinoma.
Mazzaferri EL; Robyn J
Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution.
Dardas M; Abboud M; Salti I; Sabri A; Shoucair M; Saleh M; Azar S; Rodriguez-Galindo C; Muwakkit S
Pediatr Hematol Oncol; 2009 Sep; 26(6):439-47. PubMed ID: 19657994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]